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Abstract Apoptosis, known as programmed cell death,
plays a crucial role in normal development and tissue
homeostasis. Apoptosis is also involved in neurodegener-
ative diseases such as Alzheimer’s disease. Amnesia refers
to the loss of memory and can also be a warning sign of
neurodegenerative diseases. The antioxidant properties of
Ginkgo biloba extract was known previously. Therefore,
the aim of this study was to examine the effects of Ginkgo
biloba extract on the rat’s hippocampal apoptotic neurons
number after Scopolamine based amnesia. Thirty-six adult
male Wistar rats were used. Rats were randomly divided
into control, sham, protective and treatment groups. The
rats in the sham group received only scopolamine hydro-
bromide (3 mg/kg) intraperitoneally. The rats in the pro-
tective and treatment groups received Ginkgo biloba
extract (40, 80 mg/kg) for 7 days intraperitoneally before/
after scopolamine injection. Then 48 h after the last
injection, the brains of rats were withdrawn and fixed with
paraformaldehyde, and then, after histological processing,
the slices were stained with the TUNEL kit for apoptotic
neurons. Data were compared by the ANOVA Post Hoc
Tukey test; P \ 0.05 was considered significant. Our
results showed that Scopolamine (in the sham group)
increased significantly the number of apoptotic neurons in
all areas of the hippocampus compared with the control.
Whereas, Ginkgo biloba extract reduce the neuronal
apoptosis in the hippocampus before and/or after encounter
with scopolamine. We concluded that pretreatment and
treatment injection of Ginkgo biloba extract can have a
protective effect for neurons and it can limit apoptosis in
all area of the hippocampus.
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Introduction
Some antagonists of the muscarinic cholinergic receptor,
such as scopolamine, impair memory performance that has
been proposed as an animal model of dementia (Azami et al.
2010; Caine et al. 1981). It could pass through the brain–
blood Barrier and by blocking the conduction of thecho-
linergic system, scopolamine could decrease neuronal
excitability and induce memory impairment (Zhong et al.
2005); and it can decrease the number of neurons in nervous
tissue such as the hippocampus (Seifhosseini et al. 2011).
Similarities between Alzheimer patients and scopolamine
treated animals have been reported (Azami et al. 2010).
Programmed cell death or apoptosis is a firmly con-
trolled process in which cell death is performed through the
activation of specific signaling pathways (Pulido and Par-
rish 2003). It plays a crucial role in normal development
and tissue homeostasis (Woodle and Kulkarni 1998).
Nevertheless, incorrect or unnecessary apoptosis has been
associated in several neurological disorders such as Par-
kinson’s disease and Alzheimer’s disease (Smith et al.
1991; Thompson 1995; Johnson et al. 1995; Lee et al.
2003; Liu et al. 1998). Neuronal apoptosis in the cortex and
hippocampus changes learning and memory (Kuhn et al.
2005; Sun et al. 2009).
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Apoptosis occurs when internal monitors recognize
damage or malfunction and initiate signaling cascades that
eventually activate caspases and endonucleases that kill the
cell (Kokileva 1994; Zhivotovsky et al. 1994). Antioxidant
materials are produced by the body in the form of enzymes
and also come through a person’s dietary intake. Cells
contain endogenous antioxidant enzymes (e.g., catalase,
superoxide dismutase, and glutathione peroxidase), and
many, but not all, human cancer cell types have decreased
antioxidant enzyme levels compared to their normal tissue
counterparts (Coursin et al. 1996; Oberley and Oberley
1997). The chemical structure of antioxidants enables them
to absorb the excess charges produced by free radicals.
Ginkgo biloba is one of the widely cultured Chinese
plants (Das et al. 2002), it has antioxidant and free radical-
scavenger properties which could contribute to its neuro-
protective/anti-apoptotic activity. It has also been shown to
reverse the age-related decline of neurotransmitter systems
(Williams et al. 2004). A standardized extract of the leaves
of Ginkgo biloba (EGb 761) has neuroprotective and
antioxidant properties (Seif-El-Nasr and Abd El-Fattah
1995; DeFeudis 1998). EGb 761 shows a broad range of
biochemical and pharmacological activities such as anti-
oxidants and free radical scavenging (Marcocci et al.
1994a, b) as well as neurotrophic activities in the hippo-
campal formation (Barkats et al. 1994; Krisˇtofikova´ and
Klaschka 1997).
An extract obtained from the leaves of Ginkgo biloba,
EGb761, has been used increasingly over the last decade
for the treatment of various cardiovascular- and central-
nervous system- related diseases such as ischemia,
dementia and depression (Gertz and Kiefer 2004; Smith
and Luo 2004). Unfortunately, the mechanism of its ther-
apeutic effect, particularly on the central nervous system,
remains unknown (Smith and Luo 2004; DeFeudis and
Drieu 2000; Ahlemeyer and Krieglstein 2003).
The hippocampus is involved in learning and memory
(Emamian et al. 2010) and in the other functions of the
limbic system. The main cells in the hippocampus are
pyramidal neurons and in dentate gyrus they are granular
neurons (Jahanshahi et al. 2006). Therefore, the aim of this
study was to examine the protective and treatment effects
of Ginkgo biloba extract on the neurons apoptosis in rat
hippocampus before and/or after exposure to scopolamine.
Methods
Animals
Thirty-six adult male wistar rats, weighing 200–250 g,
were used in this study. They were given free access to
normal laboratory chow and water. Temperature of the
animal house was 22 ± 3 C under a 12/12 h light–dark
cycle (light beginning at 7:00 a.m.) at least 1 week before
the beginning of the experiments. The Golestan University
of Medical Sciences Guidelines for the Care and Use of
Animals in Research were followed. Also this study was
approved by Ethics committee of Golestan University of
medical sciences.
The rats were randomly distributed into Six groups
(n = 6) as follows:
– Control: Without receiving Ginkgo biloba extract and
scopolamine.
– Sham: Scopolamine injection on the first day, 3 mg/kg
(One injection), Intra-peritoneally (IP).
– Pretreatment (two groups): Ginkgo biloba extract
injection (40 and 80 mg/kg, IP) everyday injection
for a week, Scopolamine injection on the eighth day
(3 mg/kg, IP; One injection).
– Treatment (two groups): Scopolamine injection on the
first day (3 mg/kg, IP; One injection), Ginkgo biloba
Extract injection (40 and 80 mg/kg, IP) everyday
injection for a week. Rats were injected with a single
dose of scopolamine in all groups except Control
group.
Drugs
The drugs included scopolamine hydrobromide (Tocris,
UK) and Ginkgo biloba Extract (NIAC Pharmaceutical
Factory, Gorgan, Iran). All drugs were dissolved in sterile
saline and were injected into the peritoneal.
Then 48 h after the last injection, animals anesthetized
with chloroform and their brains were withdrawn and then
the brains fixed for 2 weeks in 4 % paraformaldehyde.
Histological processing include: dehydration with different
degrees of alcohol (50–100), clarification with Xylol and
then embedding in paraffin wax, were performed.
The 8 lm coronal sections were serially collected from
Bregma -3.30 to -6.04 mm of the hippocampal formation
(Paxinos and Watson 1998). An interval of 20 lm was
placed between each two consecutive sections (Jahanshahi
et al. 2011).
Briefly, sections were deparaffinized, rehydrated, and
washed with distilled water. The sections were covered
with proteinase K solution (IHC World, USA) and incu-
bated for 15 min at 37 C in a humidified chamber.
Endogenous peroxidase activity was blocked by incubation
in 0.3 % hydrogen peroxide in PBS at room temperature
for 10 min. The sections were examined for apoptotic cells
by the terminal deoxynucleotidyl transferase mediated
dUTP nick end-labelling (TUNEL) method, using an in situ
cell death detection kit (POD, Roche, Germany), according
to the manufacturers protocol. The sections were incubated
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with the TUNEL reaction mixture at 37 C for 60 min and
then sections were incubated with Converter-POD at 37 C
for 30 min. Then sections were stained with diam-
inobenzidine (DAB) (IHC World, USA) and counterstained
lightly with Meyer’s haematoxylin.
A photograph of each section was produced using a
microscope (BX51, Olympus, Tokyo) and a DP 12 digital
camera under a magnification of 400. An area of
30000 lm2 for CA1, CA3 and dentate gyrus was selected
randomly in the all sections. To measure the area density of
the apoptotic neurons, the images were transferred onto a
computer. Using OLYSIA Autobioreport software (Olym-
pus), the appropriate grids were superimposed on the pic-
tures and the cells were counted manually (Jahanshahi
et al. 2008, 2009).
Statistical analysis
Experimental results concerning this study were evaluated
using SPSS ver. 11.5 (SPSS Inc., Chicago, IL, USA) and
expressed as mean ± SD. To compare the means of the
measured parameters in the three groups by the analysis of
variance test, after confirmation of normality, the means
were compared by the ANOVA Post Hoc Tukey test;
P \ 0.05 was considered significant.
Results
We found that in sham-scopolamine group injection of
scopolamine increased the number of apoptotic neurons in
CA1 area (P \ 0.001), CA3 area (P \ 0.01) and in dentate
gyrus (P \ 0.001) of hippocampal formation compared to
controls (Figs. 1, 2, 3, 4). All differences were significant
statistically. The most apoptotic cells were shown in den-
tate gyrus with means 16.12 ± 7.3 in the sham-scopol-
amine group compared to the other groups (Fig. 3).
Also, our data showed that the number of apoptotic cells
in experimental groups (Ginkgo Groups) was more than the
control group, But, there are no statistically significant
differences between control groups and the other experi-
mental groups that received G. biloba extract.
We found that G. biloba extract could reduce the
number of apoptotic cells in the hippocampus within
7 days after injection of scopolamine (as treatment groups
40 and 80 mg/kg). On the other hand, after injection of
scopolamine, the number of apoptotic cells was increased,
and then after treated with G. biloba, the number of
apoptotic cells in all area of the hippocampus was
decreased (Figs. 1, 2, 3).
Also, we found that administration of G. biloba 7 days
before scopolamine injection could protect the neurons
against apoptosis (Figs. 1, 2, 3). The lesser number of
apoptotic cells was observed in 40 mg/kg pretreatment
groups in CA1, CA3 and DG.
Discussion
Our data showed that scopolamine as a non-selective
muscarinic receptor antagonist can induce apoptosis in
Fig. 1 Shows the mean number of apoptotic cells in CA1 area of
hippocampus. The difference between control and sham-scopolamine
was significant statistically (P \ 0.001)
Fig. 2 Shows the mean number of apoptotic cells in CA3 area of
hippocampus. The difference between control and sham-scopolamine
was significant statistically (P \ 0.01)
Fig. 3 Shows the mean number of apoptotic cells in DG area of
hippocampus. The difference between control and sham-scopolamine
was significant statistically (P \ 0.001)
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hippocampal neurons. Regardless of the mechanism of this
induction, scopolamine increases the number of apoptotic
neurons in all area of the hippocampus. Due to the Ginkgo
biloba antioxidant property, pretreatment and treatment
groups in this study showed the lesser number of apoptotic
cells compared with sSham-scopolamine group in all areas
of the hippocampus.
The ability of G. biloba to inhibit apoptosis seemed to
depend on some factors such as: the species and the age of
the animals and also the model used for the induction of
apoptosis (Ahlemeyer et al. 1999). The neuroprotective
effect of G. biloba extract has been demonstrated in several
in vitro and in vivo models. In vitro, 10–100 lg/ml EGb
761 protected cultured neurons against death induced by
hypoxia, nitric oxide (NO) (Bastianetto et al. 2000b) and
cyanide (Krieglstein et al. 1995). Also reduction of neu-
ronal damage by intraperitoneally injection of EGb 761 has
been detected after transient middle cerebral artery occlu-
sion in rats (Krieglstein et al. 1995; Zhang et al. 2000).
Previously in cultured hippocampal neurons, it has been
shown that EGb 761 prevents neuronal death probably by a
mechanism involving its antioxidant and hydroxyl radical
scavenging activity (Bastianetto et al. 2000a). In addition,
in vitro studies have shown protective effects of EGb 761
against neuronal apoptotic death induced by hydroxyl
radicals (Bastianetto et al. 2000b; Chen et al. 1999; Ni et al.
1996; Wei et al. 2000), and some of the constituents of
G. biloba extract prevent cell death induced by serum
deprivation and staurosporine exposure in cultured chick
telencephalic neurons and hippocampal cultured neurons
(Ahlemeyer et al. 1999). G. biloba may inhibit toll-like
receptor 4 (TLR-4) and NF-jB-dependent inflammatory
responses, and, furthermore, lessen neuronal cell apoptosis
after traumatic brain injury (Yu et al. 2012). Ginkgolide B
may significantly inhibit Ab25–35-induced apoptosis, and
the neuroprotective effects may be intimately associated
with brain-derived neurotrophic factor up-regulation
caused by Ginkgolide B (Xiao et al. 2010).
Also, the ability of oxidative stress to induce apoptosis,
and the effect of Ginkgo biloba extract (EGb761) on this
induction were studied in primary cultured rat cerebellar
neuronal cells (Ni et al. 1996).
Some previous studies provide further evidence for the
therapeutic potential of EGb 761 in the treatment of vas-
cular dementia (Rocher et al. 2011). Both EGb 761 and
bilobalide have a protective effect against ischemia-
induced neuronal death in vivo (Chandrasekaran et al.
2003; Domorakova et al. 2006) and glutamate induced
neuronal death in vitro (Chandrasekaran et al. 2003).
The neuroprotective effects of EGb 761 on reduction of
the dopamine neuron loss in the substantia nigra and striata
indicates a possible role for the extract in the treatment of
Parkinson’s disease (Kim et al. 2004), these effects might
be related to the increase of bcl-2 activation, maintenance
Fig. 4 The apoptotic cells (Red arrows) in CA1 area of hippocampus in all groups (mag. 9100), Black arrows showed the normal neurons.
a control, b sham-scopolamine, c Treatment 40 mg/kg, d Treatment 80 mg/kg, e Pretreatment 40 mg/kg, f Pretreatment 80 mg/kg
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of MMP stability and decrease of caspase-3 activation
through the mitochondria-dependent pathway (Kang et al.
2007).
Conclusion
We conclude that the pretreatment and treatment injection
of Ginkgo biloba extract can have a protective effect for
neurons in all areas of hippocampal formation. On the
other hand, Ginkgo biloba extract reduced the number of
apoptotic cells in the hippocampus before or after
encounter with scopolamine. There is no difference in
effect in apoptotic cell density between different doses of
Ginkgo biloba extract that we used in this study.
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